rituximab,epcoritamab,lenalidomide
abbvie,genmab
[' lena', 'epcoritamab', 'lenalidomide', 'ritux', 'lymsm']
 presented attractive data of epcoritamab in combination with rituximab + lenalidomide in 1l and r/r settings #ash2022 #lymsm
Research Fellow @MSKCancerCenter Hematologist @hospitalclinic #Lymphoma #CLL.